CU23422B7 - Derivados de hidroxi-tetrahidro-naftalenilurea - Google Patents
Derivados de hidroxi-tetrahidro-naftalenilureaInfo
- Publication number
- CU23422B7 CU23422B7 CU20040254A CU20040254A CU23422B7 CU 23422 B7 CU23422 B7 CU 23422B7 CU 20040254 A CU20040254 A CU 20040254A CU 20040254 A CU20040254 A CU 20040254A CU 23422 B7 CU23422 B7 CU 23422B7
- Authority
- CU
- Cuba
- Prior art keywords
- pain
- derivatives
- tetrahydro
- useful
- treatment
- Prior art date
Links
- 208000002193 Pain Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 208000004296 neuralgia Diseases 0.000 abstract 2
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical class C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 206010020853 Hypertonic bladder Diseases 0.000 abstract 1
- 206010021639 Incontinence Diseases 0.000 abstract 1
- 208000028389 Nerve injury Diseases 0.000 abstract 1
- 208000009722 Overactive Urinary Bladder Diseases 0.000 abstract 1
- 208000004550 Postoperative Pain Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 230000008764 nerve damage Effects 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 201000001119 neuropathy Diseases 0.000 abstract 1
- 230000007823 neuropathy Effects 0.000 abstract 1
- 208000020629 overactive bladder Diseases 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0210512.0A GB0210512D0 (en) | 2002-05-08 | 2002-05-08 | Tetrahydro-napthalene derivatives |
| GBGB0227262.3A GB0227262D0 (en) | 2002-05-08 | 2002-11-21 | Tetrahydro-naphthalene derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU23422B7 true CU23422B7 (es) | 2009-09-08 |
Family
ID=9936269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20040254A CU23422B7 (es) | 2002-05-08 | 2004-11-04 | Derivados de hidroxi-tetrahidro-naftalenilurea |
Country Status (13)
| Country | Link |
|---|---|
| KR (1) | KR101000688B1 (fr) |
| AR (1) | AR039983A1 (fr) |
| CU (1) | CU23422B7 (fr) |
| DO (1) | DOP2003000642A (fr) |
| EC (1) | ECSP045413A (fr) |
| GB (2) | GB0210512D0 (fr) |
| GT (1) | GT200300102A (fr) |
| MA (1) | MA30728B1 (fr) |
| MY (1) | MY155011A (fr) |
| PE (1) | PE20040363A1 (fr) |
| PT (1) | PT1506167E (fr) |
| UA (1) | UA77301C2 (fr) |
| ZA (1) | ZA200408993B (fr) |
-
2002
- 2002-05-08 GB GBGB0210512.0A patent/GB0210512D0/en not_active Ceased
- 2002-11-21 GB GBGB0227262.3A patent/GB0227262D0/en not_active Ceased
-
2003
- 2003-04-28 UA UA20041210079A patent/UA77301C2/uk unknown
- 2003-04-28 PT PT03722554T patent/PT1506167E/pt unknown
- 2003-04-28 KR KR1020047017969A patent/KR101000688B1/ko not_active Expired - Fee Related
- 2003-05-05 GT GT200300102A patent/GT200300102A/es unknown
- 2003-05-06 MY MYPI20031696A patent/MY155011A/en unknown
- 2003-05-07 DO DO2003000642A patent/DOP2003000642A/es unknown
- 2003-05-07 PE PE2003000445A patent/PE20040363A1/es not_active Application Discontinuation
- 2003-05-08 AR ARP030101614A patent/AR039983A1/es active IP Right Grant
-
2004
- 2004-11-04 CU CU20040254A patent/CU23422B7/es unknown
- 2004-11-05 MA MA27935A patent/MA30728B1/fr unknown
- 2004-11-05 ZA ZA2004/08993A patent/ZA200408993B/en unknown
- 2004-11-08 EC EC2004005413A patent/ECSP045413A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1506167E (pt) | 2007-12-10 |
| KR101000688B1 (ko) | 2010-12-10 |
| GB0227262D0 (en) | 2002-12-31 |
| KR20040108784A (ko) | 2004-12-24 |
| MA30728B1 (fr) | 2009-10-01 |
| ECSP045413A (es) | 2005-01-03 |
| DOP2003000642A (es) | 2003-11-15 |
| PE20040363A1 (es) | 2004-07-03 |
| GT200300102A (es) | 2004-03-17 |
| MY155011A (en) | 2015-08-28 |
| GB0210512D0 (en) | 2002-06-19 |
| UA77301C2 (en) | 2006-11-15 |
| AR039983A1 (es) | 2005-03-09 |
| ZA200408993B (en) | 2006-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE370118T1 (de) | Tetrahydronaphtalen-derivate | |
| DOP2013000105A (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis | |
| AR058679A1 (es) | Preparacion farmaceutica que contiene meloxicam | |
| MX343215B (es) | Composiciones farmacéuticas del compuesto espiro-oxindol para administración tópica y sus usos como agentes terapéuticos. | |
| DK1506167T3 (da) | Hydroxy-tetrahydro-naphthalenylurinstofderivater | |
| BR112014017780A8 (pt) | Compostos de sulfona tricíclicos e métodos para fazer e usar os mesmos | |
| BR112012025015A2 (pt) | formulações farmacêuticas para tratamento de bexiga hiperativa. | |
| AR040248A1 (es) | Farmaco para el tratamiento de la vejiga hiperactiva | |
| CL2008002747A1 (es) | Compuestos derivados de furo y tienopirimidina; composicion farmaceutica; metodo para modular la actividad del receptor de histamina h4; y uso en el tratamiento de trastornos tales como inflamacion, trastornos alergicos, dermatologicos, entre otros. | |
| WO2011056033A3 (fr) | Composition pharmaceutique pour prévenir ou traiter des maladies associées à l'activité trpv1 ou des maladies ou affections associées à l'inflammation, contenant un peptide de maillard séparé de sauce de soja traditionnelle correctement vieillie en tant que substance active | |
| CR20210686A (es) | Análogos de 3–(5–metil–1,3–tiazol–2–il)–n–{(1r)–1–[2–(trifluor–metil)pirimidin–5–il]etil}benzamida | |
| EA200702204A1 (ru) | Лечение заболеваний соединительной ткани кожи | |
| DK1572632T3 (da) | Tetrahydro-naphthalenderivater som vanilloidreceptorantagonister | |
| AR081253A1 (es) | Uso de la tierra de diatomeas en la industria farmaceutica | |
| CL2024001231A1 (es) | Formas cristalinas de derivados de quinazolina, preparación, composición y uso de estas | |
| ECSP045413A (es) | "derivados de hidroxi-tetrahidro-naftalenilurea" | |
| ATE442864T1 (de) | Pharmazeutische zusammensetzung mit einem organopolysiloxan-elastomer und einem lösungsmittel-aktivwirkstoff | |
| UY27794A1 (es) | Derivados de hidroxi tetrahidro-naftalenilurea | |
| EA201200753A1 (ru) | Фармацевтическая композиция для лечения заболеваний мочевого пузыря | |
| ITMI20031941A1 (it) | Composizioni farmaceutiche topiche per il trattamento delle dermatiti | |
| BR112013015489A2 (pt) | combinação e composição para o tratamento de obesidade | |
| NO20064196L (no) | Utvortes preparat for behandling av smertefulle hudskader | |
| WO2012060594A3 (fr) | Composition anti-inflammatoire contenant un composé thiourée et un sel pharmaceutiquement acceptable de celui-ci en tant que principe actif | |
| UY31669A1 (es) | "formulación farmacéutica que comprende oxabispidinas /236" | |
| EA201891380A1 (ru) | Состав для лечения заболеваний периферических суставов, суставов позвоночника и/или элементов внеклеточного матрикса соединительной ткани, способ производства и применения |